M&A Deal Summary

22nd Century Group Acquires GVB Biopharma

On May 13, 2022, 22nd Century Group acquired life science company GVB Biopharma

Acquisition Highlights
  • This is 22nd Century Group’s 1st transaction in the Life Science sector.
  • This is 22nd Century Group’s 1st transaction in the United States.
  • This is 22nd Century Group’s 1st transaction in Nevada.

M&A Deal Summary
Date 2022-05-13
Target GVB Biopharma
Sector Life Science
Buyer(s) 22nd Century Group
Deal Type Add-on Acquisition
Advisor(s) Cowen Group, Inc. (Financial)
Dorsey & Whitney (Legal)

Target

GVB Biopharma

Las Vegas, Nevada, United States
GVB Biopharma is a vanguard of the organic cultivation, research, development, and marketing of hemp-based wellness solutions for suppliers, customers, and consumers around the globe. GVB Biopharma was founded in 2016 and is based in Las Vegas, Nevada.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

22nd Century Group

Mocksville, North Carolina, United States
Category Company
Founded 1998
Sector Life Science
Employees64
Revenue 32M USD (2023)
DESCRIPTION

22nd Century Group is a plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century Group is based in Buffalo, New York.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 3
State (Nevada) 1 of 1
Country (United States) 1 of 2
Year (2022) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-24 RX Pharmatech

Bradford, United Kingdom

RX Pharmatech is a distributor of cannabinoids with 1,276 novel food applications with the U.K. Food Standards Agency (FSA). RX Pharmatech is based in Bradford, United Kingdom.

Buy -
Mergr

Product

Company

Legal